GOLDMAN SACHS GROUP INC - ARTELO BIOSCIENCES INC ownership

ARTELO BIOSCIENCES INC's ticker is ARTL and the CUSIP is 04301G201. A total of 3 filers reported holding ARTELO BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ARTELO BIOSCIENCES INC
ValueSharesWeighting
Q2 2020$17,000
+21.4%
14,2230.0%0.00%
Q1 2020$14,000
-63.2%
14,2230.0%0.00%
Q4 2019$38,000
+11.8%
14,223
-9.0%
0.00%
Q3 2019$34,00015,6240.00%
Other shareholders
ARTELO BIOSCIENCES INC shareholders Q3 2020
NameSharesValueWeighting ↓
KEYSTONE WEALTH PARTNERS 15,000$7,0000.00%
Snowden Capital Advisors LLC 110,000$49,0000.00%
Virtu Financial LLC 23,801$11,0000.00%
UBS Group AG 18,283$8,0000.00%
WELLS FARGO & COMPANY/MN 260$00.00%
NORTHERN TRUST CORP 62,521$28,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 167,826$75,0000.00%
STATE STREET CORP 13,039$6,0000.00%
CREATIVE FINANCIAL DESIGNS INC /ADV 1,075$00.00%
View complete list of ARTELO BIOSCIENCES INC shareholders